- 2024-08-20 01:54抑制剂ERAP1-IN-1|ERAP1-IN-1|865273-97-8|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:54抑制剂ERAP1-IN-1|ERAP1-IN-1|865273-97-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂Eprotirome|Eprotirome|355129-15-6|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:54抑制剂EPZ004777|EPZ004777|1338466-77-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂EPZ011989|EPZ011989|2095432-26-9|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:54抑制剂ER proteostasis regulator-1|ER proteostasis regulator-1|912777-95-8|Adamas life|≥98%（以实测数值为准）|BR|
- 2024-08-20 01:54抑制剂Epitalon|Epitalon|307297-39-8|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:54抑制剂Epitalon|Epitalon|307297-39-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂Epitalon|Epitalon|307297-39-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂Enpatoran盐酸盐|Enpatoran hydrochloride|2101945-93-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂EP31670|NEO2734|2081072-29-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:54抑制剂Enbezotinib|Enbezotinib|2359649-81-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂Enpatoran盐酸盐|Enpatoran hydrochloride|2101945-93-9|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:54抑制剂Enpatoran盐酸盐|Enpatoran hydrochloride|2101945-93-9|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂EN4|EN4|1197824-15-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂Enbezotinib|Enbezotinib|2359649-81-1|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:54抑制剂Enbezotinib|Enbezotinib|2359649-81-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂Emavusertib|Emavusertib|1801344-14-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂Emavusertib|Emavusertib|1801344-14-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂EN4|EN4|1197824-15-9|Adamas life|≥98%（以实测数值为准）|BR|1mg
